U.S. LICENSE AGREEMENT This Agreement, effective as of the date of execution by both parties, is by and between THE PROCTER & GAMBLE COMPANY, an Ohio Corporation having a principal place of business at One Procter & Gamble Plaza, Cincinnati, Ohio...u.s. License Agreement • April 12th, 1999 • Paragon Trade Brands Inc • Converted paper & paperboard prods (no contaners/boxes)
Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is both not material and the type of information that the registrant customarily and actually treats as private and confidential.u.s. License Agreement • November 4th, 2021 • Prothena Corp Public LTD Co • Pharmaceutical preparations • New York
This U.S. LICENSE AGREEMENT (this “Agreement”) is entered into and made effective as of July 30, 2021 (the “Effective Date”) by and between Prothena Biosciences Limited, an Irish limited company (“Prothena”) and Celgene Switzerland LLC, a Delaware limited liability company (“Celgene”). Celgene and Prothena are each referred to herein by name or as a “Party” or, collectively, as the “Parties”.
Re: Notification to City of Hopeu.s. License Agreement • January 5th, 2012 • Vical Inc • Biological products, (no disgnostic substances)
Reference is made to the U.S. License Agreement dated July 12, 2011 (“U.S. License Agreement”) between Vical Incorporated (“Vical”) and Astellas Pharma Inc. (“Astellas”), which provides for Vical’s grant of the sublicense to Astellas under U.S. Patent No. 6,133,433 (“Subject Patent”), which has been licensed to Vical by City of Hope.
Contractu.s. License Agreement • November 4th, 2011 • Vical Inc • Biological products, (no disgnostic substances) • New York
THIS U.S. LICENSE AGREEMENT (the “Agreement”) is entered into as of the Effective Date (as defined below) by and between VICAL INCORPORATED, a Delaware corporation (“Vical”), having an address of 10390 Pacific Center Court, San Diego, California, 92121, USA, and ASTELLAS PHARMA INC., a company organized under the laws of Japan (“Astellas”), having an address of 3-11, Nihonbashi-Honcho 2-chome, Chuo-Ku, Tokyo 103-8411, Japan.
1ST AMENDMENT to U.S. LICENSE AGREEMENT BETWEEN VICAL INCORPORATED AND ASTELLAS PHARMA INC.u.s. License Agreement • August 8th, 2012 • Vical Inc • Biological products, (no disgnostic substances)
THIS AMENDMENT is made and entered into as of August 6, 2012 (“Amendment Effective Date”) by and between VICAL INCORPORATED, a Delaware corporation (“Vical”), having an address of 10390 Pacific Center Court, San Diego, California, 92121, USA, and ASTELLAS PHARMA INC., a company organized under the laws of Japan (“Astellas”), having an address of 3-11, Nihonbashi-Honcho 2-chome, Chuo-Ku, Tokyo 103-8411, Japan.
